ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HemaCare Corporation
NEW YORK, Dec. 16, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by HemaCare Corporation (OTCMKTS: HEMA) and its board of directors concerning the proposed acquisition of the company by Charles River Laboratories International, Inc. (NYSE: CRL). Stockholders will receive $25.40 per share of HemaCare Corporation common stock that they hold. The transaction is valued at approximately $380 million and is expected to close in the first quarter of 2020.
If you are a stockholder of HemaCare Corporation and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/hema. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC
![](https://rt.prnewswire.com/rt.gif?NewsItemId=NY69232&Transmission_Id=201912161433PR_NEWS_USPR_____NY69232&DateId=20191216)
Share this article